Find your next paid study

Deka Research and DevelopmentNCT07356089

Actual pay is set by the research site.

Community Team Lifestyle Immersion Program for Chronic Disease Prevention and Control

This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic a…

Hypertension

Meharry Medical CollegeNCT07201948

Actual pay is set by the research site.

Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On: Project 2 - Producing Outcome Measures for OTP Quality Improvement

This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet m…

Opioid Use Disorder

RTI InternationalNCT07214389

Actual pay is set by the research site.

Recovery Trajectory for Coma and Disorders of Consciousness

This study aims to better understand recovery after coma caused by serious neurologic illness or injury. Patients who are unconscious (in a coma or disorder of…

ComaDisorders of ConsciousnessCardiac Arrest (CA)+5 more

University of California, San FranciscoNCT07614074

~$10 – $675

Actual pay is set by the research site.

NAFLD (Nonalcoholic Fatty Liver Disease)

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

It is a 12-week study. The participants will follow three different diets, and during each diet period, and the participants will wear our device, and blood sa…

VA Greater Los Angeles Healthcare SystemNCT06932289

Actual pay is set by the research site.

Phase 1

Phase I Trial: CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy With Adjuvant Reirradiation for Recurrent High-Grade Glioma and Newly Diagnosed Diffuse Midline Glioma/Diffuse Intrinsic Pontine Glioma in Children and Young Adults

This is a single center Phase I study of a new adjuvant CD200 activation receptor ligand, CD200AR-L, in combination with imiquimod and GBM6-AD vaccine to treat…

Diffuse Midline Glioma, H3 K27M-MutantRecurrent High Grade Glioma

OX2 TherapeuticsNCT06305910

~$150 – $4,200

Actual pay is set by the research site.

Cognitive PerformanceAttentionReaction Time+1 more

GRANDMASTER: Gauging the Role of Alertness and Neurostimulation With Dietary Caffeine in Master-Level Chess; A Double-Blind Randomized Crossover Trial

This study will examine whether caffeine improves cognitive and competitive performance in professional chess players during tournament-style games. In a rando…

St. Louis UniversityNCT07641335

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Multicenter, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KK2430 in Participants With Hematologic Neoplasms

KK2430 ("Study Drug") as a potential treatment for people with Hematologic Neoplasms. KK2430 is an experimental drug; it has not been approved for the treatmen…

Hematologic Neoplasms

Kyowa Kirin Co., Ltd.NCT07629726

~$150 – $4,200

Actual pay is set by the research site.

Development of a Novel Cannabis Brief Intervention for Frequently-Using Emerging Adults: Pilot Randomized Trial

The purpose of this study is to compare two brief interventions targeting potentially problematic cannabis use in emerging adults (ages 18-25). Brief intervent…

Cannabis Use Disorder

Medical University of South CarolinaNCT06395389

Actual pay is set by the research site.

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (…

Smoking Behaviors

Roswell Park Cancer InstituteNCT07102082

Actual pay is set by the research site.

Effects of Fresh Mango as a Table Sugar Replacement on Postprandial Intestinal Permeability and Inflammation Following a High-Sugar Breakfast.

Systemic inflammation and intestinal hyperpermeability (disruption of the gut barrier which allows nutrient molecules and bacteria to enter the bloodstream) ar…

Healthy Participants

Ball State UniversityNCT07650058

Actual pay is set by the research site.

Phase 1

Efficacy of Topical Ruxolitinib in Acute Skin GVHD: A Pilot Study

The purpose of this study is to see if ruxolitinib, a Janus Kinase (JAK) 1/2 inhibitor, is safe for people who have acute skin graft versus host disease (GVHD)…

Acute Skin Graft Versus Host Disease (GVHD)